Haemonetics Corporation (HAE) /
The debt of Haemonetics Corporation over the past 10 years
Chart Haemonetics Corporation: liquid cash, total debt, net cash, fiscal 2017–2026 Open the chart →At the end of fiscal 2026, the latest fiscal year on file, Haemonetics Corporation had liquid cash of $245.44M and total debt of $1.22B: net debt of $979.14M. It had more debt than liquid cash at all 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($1.22B) and lowest at the end of fiscal 2018 ($253.68M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2026ended Mar 28, 2026 | $245.44M | $1.22B | -$979.14M |
| 2025ended Mar 29, 2025 | $306.76M | $1.22B | -$918.02M |
| 2024ended Mar 30, 2024 | $178.8M | $807.79M | -$628.99M |
| 2023ended Apr 1, 2023 | $284.47M | $765.89M | -$481.42M |
| 2022ended Apr 2, 2022 | $259.5M | $773.59M | -$514.09M |
| 2021ended Apr 3, 2021 | $192.31M | $707.61M | -$515.3M |
| 2020ended Mar 28, 2020 | $137.31M | $382.49M | -$245.18M |
| 2019ended Mar 30, 2019 | $169.35M | $350.12M | -$180.77M |
| 2018ended Mar 31, 2018 | $180.17M | $253.68M | -$73.51M |
| 2017ended Apr 1, 2017 | $139.56M | $314.65M | -$175.08M |
Fiscal years as Haemonetics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Haemonetics Corporation
- The revenue of Haemonetics Corporation
- The profitability of Haemonetics Corporation
- The cash flow of Haemonetics Corporation
- All of Haemonetics Corporation's financials, charted
Companies of a similar size
- BXSLBlackstone Secured Lending Fund
- SRRKSCHOLAR ROCK HOLDING CORPORATION
- EXPEAGLE MATERIALS INC
- NJRNEW JERSEY RESOURCES CORPORATION
- CGONCG Oncology, Inc.
Not investment advice. This page shows what Haemonetics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.